We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
67 hedge funds and large institutions have $34.7M invested in Atossa Therapeutics in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
360% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 5
146% more call options, than puts
Call options by funds: $480K | Put options by funds: $195K
144% more capital invested
Capital invested by funds: $14.2M → $34.7M (+$20.5M)
44% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 9
37% more funds holding
Funds holding: 49 → 67 (+18)
0.17% more ownership
Funds ownership: 0.86% → 1.03% (+0.17%)
Holders
67
Holders Change
+18
Holders Change %
+36.73%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
13
Reduced
9
Closed
5
Calls
$480K
Puts
$195K
Net Calls
+$285K
Net Calls Change
-$711K
Top Buyers
| 1 |
Millennium Management
New York
|
+$1.03M |
| 2 |
Goldman Sachs
New York
|
+$673K |
| 3 |
Morgan Stanley
New York
|
+$574K |
| 4 |
HF
HRT Financial
New York
|
+$312K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$266K |
Top Sellers
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$395K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$360K |
| 3 |
Two Sigma Investments
New York
|
-$137K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$75.1K |
| 5 |
BlackRock
New York
|
-$48.4K |
